Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Advent identifies five trends for alternatives in 2013

Friday, January 11, 2013

Beverly Chandler, Opalesque London: Advent Software has identified what it believes to be five key trends for alternatives over 2013. It writes that in 2012, the global alternative investment industry continued to grapple with the Eurozone debt crisis, a slowing of growth in Asia and the sluggishness of the US recovery. "European funds saw mixed results in a volatile market trying to come to grips with uncertainty in Greece and Spain. In Asia, hedge funds saw a return to positive performance following the previous year’s negative numbers, yet many funds in the region shut down and more may follow. US funds, too, bounced back from a down year, although overall performance has thus far lagged the S&P 500. Hedge fund capital invested in emerging markets reached record levels".

Further challenges to funds have come as they have had to assimilate and adjust to the regulatory tentacles of Dodd-Frank in the US and Europe’s AIFM Directive and EMIR. "Five years later, the effects of 2008 still reverberate" Advent says.

Based on conversations with alternative investment clients, including hedge funds, administrators and prime brokers, as well as internal consultants, the firm has identified the top five trends affecting the alternative industry in 2013. "While not scientific, these predictions are based on what we’ve heard from our investment management clients as well as the opinions of our own subject matter experts" they say.......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner